Clock Speed with Shamus Madan
Join Shamus Madan as he interviews industry leaders like Mark Cuban and Tim Draper, sharing insights on building billion-dollar businesses to inspire the next generation of entrepreneurs.
Amazon's Hiring Spree, Pfizer's Controversial COVID Vaccine
In this episode, Shamus Madan discusses Amazon's significant hiring surge and wage policies. He then delves into Pfizer's vaccine development, its market implications, and the skepticism that surrounds its announcement. The episode concludes with closing remarks.
Key Points
- Amazon has hired over 400,000 employees to meet increased demand, raising questions about their long-term employment status post-pandemic, especially as Amazon continues to enhance delivery times and may retain them unless automation technology reduces the need for human labor.
- Pfizer's announcement of a 90% effective COVID-19 vaccine has impacted stock markets, with Pfizer shares rising and stocks of companies that thrived during the pandemic, like Zoom and Peloton, experiencing declines, though skepticism from figures like Jim Kramer persists regarding the speed of the vaccine's release.
- The UK's approval of Pfizer's COVID-19 vaccine has put pressure on the FDA to assess and determine the vaccine's safety for use in the United States, while the positive feedback from Dr. Fauci on the vaccine's results has increased hopes for an earlier-than-expected vaccine rollout.
Story #1: Amazon hires over 400,000 employees to keep up with increased demand and holiday sales. The question is will these workers be laid off after demand dies down or after the pandemic?
Story #2: Pfizer’s 90% effective vaccine and what could this mean for the US economy and big tech giants like Amazon, Google, and Apple as they have received more demand during COVID as everyone is at home.
Chapters
| 0:00 | |
| 0:36 | |
| 1:39 | |
| 2:36 | |
| 3:36 |
Transcript
Loading transcript...
- / -